| Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Outline of Final Research Achievements |
I conducted research to make evidence of Kampo medicine for neurology with original system "TOMRASS" in our clinic. I paid attention to symptoms such as headache, dizziness, and numbness relatively responsive to Kampo medication. For headache, efficacy rate of gosyuyuto, goreisan, and ryokeijutsukanto was 70.0%, 58.8% and 52.9%, respectively. For dizziness, those of ryokeijutsukanto, goreisan and hangebyakujutsutenmato was 48.4%, 63.6% and 54.5%. For numbness, those of hachimijiogan was 38.4%. When I discussed about condition of patients effective to Kampo medication, for instance, ryokeijutsukanto was especially effective to patients with coldness in foot. I revealed new knowledge about Kampo medications.
|
